125 related articles for article (PubMed ID: 36827185)
1. Structure, function, and evolution of the Orthobunyavirus membrane fusion glycoprotein.
Hellert J; Aebischer A; Haouz A; Guardado-Calvo P; Reiche S; Beer M; Rey FA
Cell Rep; 2023 Mar; 42(3):112142. PubMed ID: 36827185
[TBL] [Abstract][Full Text] [Related]
2. The La Crosse virus class II fusion glycoprotein
Thannickal SA; Spector SN; Stapleford KA
J Virol; 2023 Aug; 97(8):e0081923. PubMed ID: 37578236
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Insight into Bunyavirus-Induced Membrane Fusion from Structure-Function Analyses of the Hantavirus Envelope Glycoprotein Gc.
Guardado-Calvo P; Bignon EA; Stettner E; Jeffers SA; Pérez-Vargas J; Pehau-Arnaudet G; Tortorici MA; Jestin JL; England P; Tischler ND; Rey FA
PLoS Pathog; 2016 Oct; 12(10):e1005813. PubMed ID: 27783711
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the African orthobunyavirus Ilesha virus.
Pachler K; Růžek D; Nowotny N
Infect Genet Evol; 2013 Dec; 20():124-30. PubMed ID: 23988729
[TBL] [Abstract][Full Text] [Related]
5. A Genome-Wide CRISPR-Cas9 Screen Reveals the Requirement of Host Cell Sulfation for Schmallenberg Virus Infection.
Thamamongood T; Aebischer A; Wagner V; Chang MW; Elling R; Benner C; García-Sastre A; Kochs G; Beer M; Schwemmle M
J Virol; 2020 Aug; 94(17):. PubMed ID: 32522852
[TBL] [Abstract][Full Text] [Related]
6. Targeted Mutations in the Fusion Peptide Region of La Crosse Virus Attenuate Neuroinvasion and Confer Protection against Encephalitis.
Hollidge BS; Salzano MV; Ibrahim JM; Fraser JW; Wagner V; Leitner NE; Weiss SR; Weber F; González-Scarano F; Soldan SS
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891445
[TBL] [Abstract][Full Text] [Related]
7. The La Crosse virus class II fusion glycoprotein
Thannickal SA; Spector SN; Stapleford KA
bioRxiv; 2023 Feb; ():. PubMed ID: 36865275
[TBL] [Abstract][Full Text] [Related]
8. The amino terminal subdomain of glycoprotein Gc of Schmallenberg virus: disulfide bonding and structural determinants of neutralization.
Roman-Sosa G; Karger A; Kraatz F; Aebischer A; Wernike K; Maksimov P; Lillig CH; Reimann I; Brocchi E; Keller M; Beer M
J Gen Virol; 2017 Jun; 98(6):1259-1273. PubMed ID: 28640745
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the humoral immune response against the envelope glycoprotein Gc of Schmallenberg virus reveals a domain located at the amino terminus targeted by mAbs with neutralizing activity.
Roman-Sosa G; Brocchi E; Schirrmeier H; Wernike K; Schelp C; Beer M
J Gen Virol; 2016 Mar; 97(3):571-580. PubMed ID: 26684324
[TBL] [Abstract][Full Text] [Related]
10. Orthobunyaviruses: From Virus Binding to Penetration into Mammalian Host Cells.
Windhaber S; Xin Q; Lozach PY
Viruses; 2021 May; 13(5):. PubMed ID: 34068494
[TBL] [Abstract][Full Text] [Related]
11. California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry.
Plassmeyer ML; Soldan SS; Stachelek KM; Martín-García J; González-Scarano F
Virology; 2005 Jul; 338(1):121-32. PubMed ID: 15923017
[TBL] [Abstract][Full Text] [Related]
12. Arboviruses pathogenic for domestic and wild animals.
Hubálek Z; Rudolf I; Nowotny N
Adv Virus Res; 2014; 89():201-75. PubMed ID: 24751197
[TBL] [Abstract][Full Text] [Related]
13. Orthobunyavirus spike architecture and recognition by neutralizing antibodies.
Hellert J; Aebischer A; Wernike K; Haouz A; Brocchi E; Reiche S; Guardado-Calvo P; Beer M; Rey FA
Nat Commun; 2019 Feb; 10(1):879. PubMed ID: 30787296
[TBL] [Abstract][Full Text] [Related]
14. La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic.
Soldan SS; Hollidge BS; Wagner V; Weber F; González-Scarano F
Virology; 2010 Sep; 404(2):139-47. PubMed ID: 20553924
[TBL] [Abstract][Full Text] [Related]
15. Vesicular Stomatitis Virus Chimeras Expressing the Oropouche Virus Glycoproteins Elicit Protective Immune Responses in Mice.
Stubbs SH; Cornejo Pontelli M; Mishra N; Zhou C; de Paula Souza J; Mendes Viana RM; Lipkin WI; Knipe DM; Arruda E; Whelan SPJ
mBio; 2021 Aug; 12(4):e0046321. PubMed ID: 34340542
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide.
Plassmeyer ML; Soldan SS; Stachelek KM; Roth SM; Martín-García J; González-Scarano F
Virology; 2007 Feb; 358(2):273-82. PubMed ID: 17027056
[TBL] [Abstract][Full Text] [Related]
17. Skin muscle is the initial site of viral replication for arboviral bunyavirus infection.
Schneider CA; Leung JM; Valenzuela-Leon PC; Golviznina NA; Toso EA; Bosnakovski D; Kyba M; Calvo E; Peterson KE
Nat Commun; 2024 Feb; 15(1):1121. PubMed ID: 38321047
[TBL] [Abstract][Full Text] [Related]
18. Elongin C Contributes to RNA Polymerase II Degradation by the Interferon Antagonist NSs of La Crosse Orthobunyavirus.
Schoen A; Lau S; Verbruggen P; Weber F
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941775
[TBL] [Abstract][Full Text] [Related]
19. Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.
Pekosz A; Griot C; Stillmock K; Nathanson N; Gonzalez-Scarano F
J Virol; 1995 Jun; 69(6):3475-81. PubMed ID: 7745694
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Acute Flaccid Paralysis Reported with La Crosse Virus Infection, Ohio, USA, 2008-2014.
Hennessey MJ; Pastula DM; Machesky K; Fischer M; Lindsey NP; DiOrio M; Staples JE; de Fijter S
Emerg Infect Dis; 2017 Dec; 23(12):2075-2077. PubMed ID: 29148398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
